Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1985-5-28
|
pubmed:abstractText |
The effects of an antirheumatic agent, N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96), were investigated on allergic reactions in rats and guinea pigs. The effects of SA96 were compared with those of D-penicillamine (D-Pc). SA96 given twice orally at the doses of 10 to 50 mg/kg significantly caused inhibitions of 28%, 29% and 44% against passive cutaneous anaphylaxis (PCA), reversed cutaneous anaphylaxis (RCA) and reversed passive Arthus (RPA) reactions, which are classified as Type I, Type II and Type III allergic reactions, respectively. D-Pc also showed inhibitions of 30%, 23% and 18% on Type I, Type II and Type III reactions, respectively, and inhibitions on Type II and Type III reactions were not significant. On the other hand, SA96 (10 to 50 mg/kg twice) had no influence on the Type IV allergic reaction, delayed hypersensitivity, while D-Pc (20 mg/kg twice) showed an enhancement of 27% on the Type IV reaction. In the in vitro study, SA96 inhibited the hemolytic complement activity at 10(-4) to 10(-2) M and the macrophage migration at 1 X 10(-4) to 5 X 10(-3) M in a dose-dependent manner. These in vitro activities of SA96 were more potent than those of D-Pc. These results showed that SA96 had some different immunopharmacological properties on experimental allergic reactions as compared with those of D-Pc.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0021-5198
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-90
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3157817-Anaphylaxis,
pubmed-meshheading:3157817-Animals,
pubmed-meshheading:3157817-Anti-Inflammatory Agents,
pubmed-meshheading:3157817-Arthus Reaction,
pubmed-meshheading:3157817-Cell Migration Inhibition,
pubmed-meshheading:3157817-Complement Activation,
pubmed-meshheading:3157817-Cysteine,
pubmed-meshheading:3157817-Guinea Pigs,
pubmed-meshheading:3157817-Hemolysis,
pubmed-meshheading:3157817-Hypersensitivity,
pubmed-meshheading:3157817-Hypersensitivity, Delayed,
pubmed-meshheading:3157817-Immunoglobulin E,
pubmed-meshheading:3157817-Macrophages,
pubmed-meshheading:3157817-Male,
pubmed-meshheading:3157817-Passive Cutaneous Anaphylaxis,
pubmed-meshheading:3157817-Rats,
pubmed-meshheading:3157817-Rats, Inbred Strains
|
pubmed:year |
1985
|
pubmed:articleTitle |
Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96) (3). Effects of SA96 on experimental allergic reactions.
|
pubmed:publicationType |
Journal Article
|